Transaction DateRecipientSharesTypePriceValue
18th February 2021Dan Puckett3,080Payment by withholding$123.19$379,425.20
18th February 2021Isaac Zacharias3,719Payment by withholding$123.19$458,143.61
17th February 2021James E Flynn32,884Open or private purchase$19.00$624,796.00
17th February 2021James E Flynn133,558Open or private purchase$19.00$2,537,602.00
9th February 2021James E Flynn1,717,033Conversion of derivative$0.00
9th February 2021James E Flynn665,000Open or private purchase$17.00$11,305,000.00
8th February 2021Laura Francis9,839Open or private sale$33.10$325,718.13
8th February 2021Laura Francis9,839Exercise of derivative$4.32$42,504.48
5th February 2021Laura Francis803Exercise of derivative$4.32$3,468.96
5th February 2021Laura Francis803Open or private sale$33.10$26,579.30
Shockwave Medical
Shockwave Medical logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.

Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease.

Ticker: SWAV
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1642545
Employees: 284
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags